What’s happening – Covid19-ARDs trial?
Early doors there was mention that there was to be recruitment of 300 patients from 30 sites America wide and a rapid mobilisation with expectancy of early enrolment given the dire situation. This has been moderated to more than 20 centres to the latest mention of more than 17 centres.
What; there is the sudden realisation that there are no/insufficient takers for this trial to complete the required 300 enrolment? That to reach the 300 target there is a need to reach out and engage with other hospitals (in Australia) that may be more amenable/interested? Is the 300 patient enrolment a necessary requirement before the release of a preliminary trial report?
Is NIH administering/funding the Australian component of the trial? or has NIH just failed to deliver/or has dragged its heels regarding recruitment? I’m getting the feeling that this blinded trial might be more a case of the blind leading the blind, but I DON’T KNOW, -requires a Pauline Hansen.
Ann: Ethics Approval to Treat COVID-19 Patients in Australia, page-144
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10425 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 44243 | 5 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |